| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |